Back to Top

Systemic Lupus Erythematosus

Get Help with Your Treatment

Apply Online or call 1-866-316-7263

 

Program Status

Currently Closed – We are no longer accepting or processing applications for new or renewal patients.

 

The PAN Foundation’s Systemic Lupus Erythematosus fund is currently closed. As of February 14, 2018, Healthwell and The Assistance Fund are accepting applications. 

Maximum Award Level

$6,300 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for the disease named in the assistance program to which he or she is applying.
  2. The patient must have health insurance that covers his or her qualifying medication or product. 
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 500% of the Federal Poverty Level. 
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Azasan (azathioprine)
  • Azathioprine (azathioprine)
  • Benlysta (belimumab)
  • Cellcept (mycophenolate mofetil)
  • Chloroquine Phosphate (chloroquine phosphate)
  • Cyclophosphamide (cyclophosphamide)
  • Cyclosporine Modified (cyclosporine, modified)
  • Deltasone (prednisone)
  • Depo-Medrol (methylprednisolone acetate)
  • Gengraf (cyclosporine, modified)
  • Hydroxychloroquine Sulfate (hydroxychloroquine sulfate)
  • Imuran (azathioprine)
  • Methotrexate Sodium (methotrexate sodium/pf)
  • Methylprednisolone (methylprednisolone)
  • Mycophenolate Mofetil (mycophenolate mofetil)
  • Neoral (cyclosporine, modified)
  • Otrexup (methotrexate/pf)
  • P-Care (methylprednisolone acetate)
  • Plaquenil (hydroxychloroquine sulfate)
  • Prednisone (prednisone)
  • Rasuvo (methotrexate/pf)
  • Rayos (prednisone)
  • Restasis Multidose (cyclosporine)
  • Rheumatrex (methotrexate sodium)
  • Sandimmune (cyclosporine)
  • Trexall (methotrexate sodium)
  • Xatmep (methotrexate)
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Diagnosis Codes:

ICD-10: M32.10-M32.15, M32.8-M32.9, M32.19

Related Organizations: